Dear Colleagues,

Hearing loss is an enormous global health challenge which continues to evade mainstream drug therapeutics. Hearing loss can be caused by a variety of factors such as aging, chronic ear disease, diabetes, drugs (ototoxocity) and noise. Other common causes include hereditary (genetic) and trauma. Despite advances in hearing aid technology and implantable hearing device surgery, the fundamental treatment of the variety of hearing loss causes remains elusive. The design and development of novel therapeutics to treat hearing loss continues to challenge researchers largely due to the dual difficulty of access to the cochlea and delivery of therapeutics to end organ cellular structures within the inner ear itself. Recently, advances in inner ear drug delivery and the development of  novel bio-nanotechnologies have gained widespread interest through the promise of more efficient drug delivery to their cellular targets within the inner ear.

This special issue will explore novel treatment strategies and technologies  which can offer new therapeutic options for patients with hearing loss from a variety of causes. We especially encourage submissions concerning basic research as well as applied research in both animal and human subjects.

Dr. Jafri Kuthubutheen
Dr. Daniel Brown
Dr. Hani Al-Salami
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Audiology Research is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Hearing loss
• Bio-nanotechnologies
• Cochlear-specific drug targeting
• Bile acids Permeation enhancers
• Hearing loss detection